In the present study, we showed that a single-dose treatment of normal breast epithelial cell line, MCF10A, for 72 h with cigarette smoke condensate (CSC) resulted in a transformed phenotype. The anchorage-dependent growth of these cells was decreased due to increased cell cycle arrest in S-G 2 /M phase; however, the surviving cells developed resistance due to an increased Bcl-xL to Bax ratio. Levels of PCNA and gadd45 proteins -involved in DNA repair in response to genomic damage -were increased, suggesting that the cells were responding to CSC-induced genomic damage. The transformation of MCF10A cells was determined by their colony-forming efficiency in soft-agar in an anchorage-independent manner. CSC-treated MCF10A cells efficiently formed colonies in soft-agar. We then re-established cell lines from the soft-agar colonies and further examined the persistence of their transforming characteristics. The reestablished cell lines, when plated after 17 passages without CSC treatment, still formed colonies in the softagar. An increased staining of neuropilin-1 (NRP-1) further showed a transformation characteristic of MCF10A cells treated with CSC. In summary, our results suggest that CSC is capable of transforming the MCF10A cells in vitro, supporting the role of cigarette smoking and increased risk for breast cancer.
Introduction
The American Cancer Society estimates more than 22 million adult women and at least 1.5 million adolescent girls in the US currently smoke cigarettes. Recently, breast cancer risk has been associated with active smoking in a large number of the California Teachers Study cohort (Reynolds et al., 2004) . A strong link between smoking, the number of cigarettes smoked, and the incidence of breast cancer in women has also been demonstrated (Morabia, 2002) . The support for a role of cigarette smoke exposure in breast cancer is suggested by several observations. First, both active and passive smoking can cause disease not only in organs directly exposed to tobacco smoke, such as the mouth and lung, but also in distant organs such as the bladder, colon, and breast. Second, the tobacco smoke contains multiple fat-soluble toxins, mutagens, and carcinogens that are known to induce mammary tumors in rodents and have been detected in breasts of women workers (Phillips et al., 2001) . Third, over 4000 compounds have been identified in cigarette smoke, 60 of which have been found to be complete carcinogens, tumor initiators, promoters and/or co-carcinogens in various in vitro and animal bioassays (Hecht, 2002) . These carcinogens can be activated into electrophilic intermediates by enzymes active in the human breast epithelial cells. Fourth, the genes coding for the activation/detoxification enzymes of these carcinogens have been reported to modify the relation of tobacco smoke to breast cancer risk. Fifth, the electrophilic metabolites of tobacco carcinogens bind to DNA and form DNA adducts. There is evidence from the 32 P-postlabeling studies that smoking-related adducts are present in the breast tissue DNA of smokers (Perera et al., 1995) . For example, electrophilic metabolites of benzo [a] pyrene (B[a]P) generate DNA adducts with the nucleophilic groups of the two purine bases, adenine and guanine (Cavalieri et al., 2000) . Sixth, the genomic alterations observed in vitro after exposure of human breast epithelial cells to the tobacco carcinogen B[a]P resemble those seen in familial breast cancer (Russo et al., 2001) . Through comprehensive studies of the DNA adducts of B[a]P, a strong association between depurinating adducts and oncogenic mutations in the Hras gene, which are generated by misrepair rather than misreplication of the apurininc sites, are suggested as the primary culprits in tumor initiation and progression (Cavalieri et al., 2000) .
Sometimes breast cancer can arise after 30-40 years after the beginning of smoking and the risk may also vary with women with certain genotypes (Terry and . There are studies that support the finding that smoking prior to a first full-term pregnancy may be an important risk factor for breast cancer development (Russo et al., 1982; Band et al., 2002; Terry and Rohan, 2002; Band, 2003) . However, in contrast to the above findings, the recent data suggest no increased risk of breast cancer in women who smoked during pregnancy (Fink and Lash, 2003) . Recently, Hamajima et al. (2002) reported that cigarette smoking has little or no independent risk of developing breast cancer. Yet, in this paper also the authors acknowledge that the quality and validity of their data were limited to a certain extent since most of the individual studies were not set up with the primary purpose of testing the role of smoking in breast cancer incidence. Another prospective study from the Nurses' Health Study reports that passive smoking is unrelated to breast cancer, but active smoking is compatible with a small increase in risk when smoking is initiated at young ages (Egan et al., 2002) . Contrary to this, passive smoking has been linked as a risk factor in other case-controlled studies (Smith et al., 1994; Lash and Aschengrau, 1999; Morabia et al., 1996; Millikan et al., 1998; Johnson et al., 2000) .
Thus, based on the epidemiologic studies, a conflicting finding of the association between cigarette smoking and breast cancer risk is observed. In the present study, we used an in vitro cell culture system with a spontaneously immortalized human normal breast epithelial cell line MCF10A and cigarette smoke condensate (CSC) to examine whether CSC-treated MCF10A cells gain any growth advantage over untreated cells. Our results suggest that most CSC-treated MCF10A cells become growth arrested while a few cells go through selection pressure and survive due to an increased expression level of the antiapoptotic gene BclxL and a decreased expression level of the proapoptotic gene Bax. These cells acquired properties of transformed cells.
Results

Growth characteristics of MCF10A cells after treatment with CSC
The spontaneously immortalized normal human breast epithelial cell line, MCF10A, has been derived from a mortalized cell line that has a finite lifespan when grown in a low calcium-containing medium . The MCF10A cells express polymorphic epithelial mucins (MEC) and keratins and are estrogen receptor (ER) negative (Tait et al., 1990; Paine et al., 1992) . These cells become immortal perhaps due to the loss of cyclindependent kinase inhibitors p15 and p16 (Stampfer and Yaswen, 2000) . The MCF10A cell line is appropriate for in vitro studies as it is nontumorigenic and retains normal functions in its growth factors, tumor suppressor p53, and anchorage-dependent growth in culture (Ciardiello et al., 1992) . In the present study, we examined the transformation and growth characteristics of the MCF10A cells after treatment with CSC. First, we examined the effect of CSC treatment on the anchoragedependent growth of MCF10A cells. We found that the growth of the MCF10A cells was decreased in a dosedependent manner after CSC treatment for 72 h (Figure 1 ). Decreased cell growth of MCF10A cells may be attributed to increased cell cycle arrest or apoptosis, a possibility that was tested by FACScan analysis. Results showed that increased cell cycle arrest at the S-G 2 /M phase rather than apoptosis contributed to the reduced growth of CSC-treated MCF10A cells (Table 1) .
Bcl-xL to Bax ratio is increased in MCF10A cells after treatment with CSC Based on the anchorage-dependent growth assay as well as FACScan analysis as described in Figure 1 and Table 1 , respectively, it is possible to conclude that CSC may not have a transforming potential for MCF10A cells. However, it should be noted that breast cancers Transformation of normal breast epithelial cells S Narayan et al originate with genetic defects that are 'clonal' in nature (Tomlinson, 2001) . Our results showed that even with toxic concentrations of CSC (50 mg/ml) treatment, about 30% of MCF10A cells survived (Figure 1 ). These results prompted us to determine the mechanisms by which some of the MCF10A cells acquire survival characteristics after CSC treatment. The expression level of several cell cycle-and apoptosis-related genes was determined. Since p53 serves as a DNA damage response-sensor and induces transcription of its target genes in cells (Pluquet and Hainaut, 2001) , we used an RNase protection assay (RPA) to determine the transcriptional expression of cell cycle-and apoptosisrelated p21, PCNA, gadd45, Bcl-2, Bax, and Bcl-xL genes (Oren, 2003) . The expression profile of these genes is shown in Figure 2a . CSC treatment significantly increased the mRNA levels of Bcl-xL and gadd45 in a dose-dependent manner, whereas the mRNA levels of p53, p21, Bax, Bcl-2, and PCNA remained unchanged ( Figure 2b ). Some increase in the c-fos mRNA level was also observed but only at a CSC concentration of 50 mg/ml. The mRNA levels of L32 and GAPDH served as an RNA loading and normalization control in these experiments. These results suggest differential regulation of the p53 target genes in CSC-treated MCF10A cells. Next, we examined whether the protein levels of p53, p21, gadd45, PCNA, Bcl-2, Bcl-xL, and Bax were altered in CSC-treated MCF10A cells (Figure 3a) . The p53, p21, and Bcl-2 protein levels were moderately increased; however, a significant increase was seen in the protein levels of PCNA, gadd45, and Bcl-xL at all the concentrations of CSC treatment except at 50 mg/ml of CSC treatment where these levels decreased but still remained more than the untreated MCF10A cells. The Bcl-2 protein level was also increased at lower concentrations but returned to the control level at higher concentrations of the CSC treatment. On the other hand, the protein level of Bax was decreased in CSCtreated MCF10A cells in a dose-dependent manner ( Figure 3a) . The increased level of PCNA and gadd45 indicate an active DNA synthesis and repair in these cells, possibly as a consequence of genomic damage caused by CSC exposure. Since the growth of these cells was retarded after CSC treatment, the results suggest that the cellular proliferation and growth retardation are in competition with each other for survival benefit. It has been reported that the increased Bcl-xL to Bax ratio provides DNA damage-induced resistance and survival to many cancer cell types (Cheng et al., 2001) . We hypothesized that the survival of the MCF10A cells 
Selective growth of MCF10A cells after treatment with CSC
To examine whether CSC treatment can transform the MCF10A cell line, we performed anchorage-independent growth of MCF10A cells treated with different concentrations of CSC for 72 h. After the treatment, cells were harvested and a single-cell suspension culture was used for the anchorage-independent growth assays in the soft-agar as described in the Materials and methods. After 4 weeks, the colonies were scored under the microscope and pictures were taken at 20 Â magnification. The criteria for the measurement of the colonies grown in the soft-agar were stringent in our assays. We considered a group of 25-50 untreated MCF10A cells as cell aggregates. Since the aggregates of the untreated MCF10A cells did not grow further throughout the experiment period, they have been not considered as colonies. Thus, the control cells did not form colonies, whereas the cells treated with CSC formed larger colonies (Figure 4a ). The number of colonies increased up to 25 mg/ml of CSC treatment, which was much higher at the 10 mg/ml of CSC treatment as compared to untreated MCF10A cells (Figure 4b ). The colony-formation efficiency of the MCF10A cells treated with 50 mg/ml of CSC was reduced to the level of untreated cells however, perhaps due to cellular toxicity that corresponds with the retardation in the anchorage-dependent growth of these cells in culture (Figure 1 ). These results indicate that many cells were dying after CSC treatment and few cells were adapting for survival under the treatment conditions. The surviving cells are presumably transformed MCF10A cells. To test whether the MCF10A cells that survived after CSC treatment were transformed, we established cell lines from randomly selected soft-agar colonies and examined their growth characteristics. As described in the Materials and methods, several cell lines were established from the CSC-treated MCF10A cells. In this experiment, we used cell lines that were established in culture for 17 passages to determine their growth properties as compared to the parental MCF10A cells. The results of the anchorage-dependent growth of four cell lines derived from MCF10A cells treated with 1 and 10 mg/ml of CSC are given here. We named these cell lines as CSC-MCF10A1 and CSC-MCF10A2 (established from the colonies of 1 mg/ml of CSC-treated MCF10A cells) and CSC-MCF10A3 and CSC-MCF10A4 (established from the colonies of 10 mg/ml of CSC-treated MCF10A cells). The anchorage-dependent growth of all the established cell lines was higher than the parental MCF10A cell line. Among the established cell lines, the anchorage-dependent growth of the CSC-MCF10A3 and CSC-MCF10A4 cell lines was much higher than the CSC-MCF10A1 and CSC-MCF10A2 cell lines ( Figure 5 ).
Next, we examined whether the transformed phenotype acquired by the established cell lines was stable. An anchorage-independent growth of the CSC-MCF10A1, CSC-MCF10A2, CSC-MCF10A3, and CSC-MCF10A4 cell lines without further CSC treatment was performed in soft-agar. We found that after 4 weeks of plating these cell lines onto the soft-agar, larger colonies were formed compared to the untreated parental MCF10A cells (Figure 6a ). The number of colonies was also increased in the established cell lines as compared to the parental MCF10A cell line (Figure 6b) . Interestingly, the number of colonies among these cell lines was different, suggesting that these cell lines may have acquired different genetic changes during the course of transformation.
Expression of neuropilin-1 (NRP-1) was increased in CSC-treated MCF10A cells
The expression of NRP-1 has been suggested as one of the markers for the neoplastic progression of breast cancer cells (Soker et al., 1998; Stephenson et al., 2002) . In the present study, we hypothesized that if CSC (Figure 7) . A significant change in the size of the cells was observed after CSC treatment. We found that cells treated with either 10 or 50 mg/ml of CSC for 72 h were larger in size. The exact cause of the increase in cell size is still not completely clear. However, one possibility is that after DNA damage by CSC treatment, cells enter into S-G 2 / M phase arrest for DNA repair but may not block DNA replication and chromosomal duplication. Thus, the blockage of mitosis and increase in DNA content may increase the size of the MCF10A cells after CSC treatment (Figure 7) . Furthermore, the increase in cell size was proportional to the increase in NRP-1 staining, suggesting that the NRP-1 is overexpressed in these cells during early stages of initiation of transformation. We further tested whether the increased levels of NRP-1 were a transient phenomenon for 72 h treatment with CSC or if its level remained elevated in the re-established cell lines. We expected that the NRP-1 levels may remain elevated in the re-established CSC-MCF10A1, CSC-MCF10A2, CSC-MCF10A3, and CSC-MCF10A4 cell lines, and this was the case. The NRP-1 levels were higher in these cell lines as compared to the parental Figure 7 Immunohistochemical analysis of NRP-1 expression in MCF10A cells treated with CSC. After treatment, cells grown on cover slips were fixed and processed for immunofluorescence staining as described in the Materials and Methods. The NRP-1 protein was stained with rhodamine-conjugated secondary antibody and nuclear heterchromatin fraction with DAPI. Photographs are representative of three independent experiments. Magnification at 40 Â Transformation of normal breast epithelial cells S Narayan et al MCF10A cell line (Figure 8 ). These results suggest that the increased NRP-1 levels in the CSC-treated parental MCF10A cell line and the cell lines derived from it are due to their conversion into a transformed phenotype.
Discussion
The results of this study clearly establish that cigarette smoke condensate is capable of transforming the normal breast epithelial cells, supporting epidemiological studies that suggest a higher risk of breast cancer in smokers (Smith et al., 1994 et al., 2003) . Whether these carcinogens, present in CSC, are responsible for transforming normal breast epithelial cells is difficult to conclude at this time since cigarette smoke also contains many other carcinogenic substances such as tumor promoters as well as inhibitors. The anchorage-dependent growth of the MCF10A cells that were decreased in response to CSC treatment can provide incomplete and misleading information about the role of cigarette smoking in breast carcinogenesis. One may think that the decreased cell growth may prevent breast carcinogenesis after cigarette smoking. However, consistent with the selective 'clonal' expansion and microenvironment permissiveness in tobacco-mediated lung carcinogenesis (Rubin, 2002) , a single transformed normal breast epithelial cell can give rise to a tumor. Thus, the main focus of our study was to examine the underlying mechanisms involved in the transformation of normal breast epithelial cells by CSC. We used four different parameters to address this question -(1) the transformed phenotype of CSC-treated MCF10A cells identified by anchorageindependent growth colony formation in soft-agar, (2) different cell lines established from soft-agar colonies derived from control and CSC-treated MCF10A cells, (3) the examination of protein and mRNA expression levels of cell cycle-and apoptosis-related genes in different cell lines were examined to assess survival advantage of the transformed cells, and (4) the use of the expression level of NRP-1 as a marker for the carcinogenic transformation of the CSC-treated MCF10A cells. Our results indicate that the MCF10A cell line acquires selective growth advantage after treatment with CSC.
From our results it appears that cells may experience CSC-induced DNA damage at all concentrations of treatment; however, the cellular responses may vary depending upon the extent of DNA damage and DNA repair capacity of the cell in different treatment conditions. It is likely that at lower concentrations of CSC treatment, the MCF10A cells experience less DNA damage, which is repaired efficiently. However, cells with compromised DNA repair capacity as well as increased expression of the antiapoptotic genes and the decreased expression of the proapoptotic genes may cause accumulation of mutation and cell survival. On the other hand, the increased DNA damage at higher concentrations of CSC treatment may not be efficiently repaired by DNA repair machinery. Although these cells may have increased expression of the antiapoptotic genes and the decreased expression of the proapoptotic genes, they may not survive due to increased cellular toxicity. However, due to selective pressure of the surrounding environment some of these can escape the cell cycle arrest and apoptosis Transformation of normal breast epithelial cells S Narayan et al and become transformed. The decreased growth of the MCF10A cells after CSC treatment was found to be due to the cell cycle arrest at S-G 2 /M phase. The fate of S-G 2 /M phase arrested cells is either death due to toxicity or proliferation and survival due to increased expression of antiapoptotic genes. In our studies, we determined cell proliferation and survival characteristics of CSC-treated MCF10A cells. The proliferative activity of MCF10A cells was determined by assessing PCNA, an accessory factor of DNA polymerase whose expression level is increased during the early G 1 and S phase of the cell cycle (Prosperi, 1997) . In the present study, we found that the expression of PCNA was increased significantly as compared to the untreated cells after CSC treatment. These findings indicated that CSC treatment increases the proliferative rate of MCF10A cells. However, it is equally possible that increased levels of PCNA reflect activation of the DNA repair process in response to genomic damage caused by CSC. The latter likelihood is more favorable since the cell cycle arrest in the S phase is increased at higher concentrations of CSC treatment. Thus, the increased levels of PCNA may cooperate in DNA repair by participating in the cell cycle arrest in S phase after CSC treatment. On the other hand, the DNA damage-inducible expression of gadd45, an indicator of growth arrest, was also increased (Sheikh et al., 2000) . Increased expression of gadd45 has been implicated in terminal differentiation (Liebermann and Hoffman, 2002), growth suppression (Zhan et al., 1994; Jin et al., 2000) , and apoptosis (Takekawa and Saito, 1998; Harkin et al., 1999) . Since CSC is a complex chemical mixture, the opposing effects of genes induced by CSC in different signaling pathways are expected (Hoffmann et al., 2001) . In previous studies it has been shown that gadd45 interacts with PCNA and may participate in DNA repair during G 1 phage arrest of cell cycle (Hall et al., 1995) . Furthermore, gadd45 also interacts with Cdc2 and disrupts the interactions of Cdc2 with cyclin B1 and induces G 2 /M phase arrest (Zhan et al., 1999) . The mechanisms by which PCNA and gadd45 might play a role in CSC-induced S-G 2 /M phase arrest as well as affect the proliferation of the MCF10A cells is currently under investigation.
Next, we determined the mechanism by which some MCF10A cells acquired resistance to cell death and cell cycle control and therefore survived after CSC treatment. There are two major components involved in the cell survival pathway that are balanced between the expression levels of proapoptotic protein Bax and anti-apoptotic protein Bcl-xL (Cheng et al., 2001 ). An increase in Bax levels causes apoptosis, while an increase in Bcl-xL levels causes cell survival. Since both of these proteins are ubiquitously expressed in all cell types, their increased or decreased ratio becomes the determining factor for cell death versus cell survival. In our studies, we found that the Bcl-xL to Bax ratio is several folds higher in CSC-treated versus untreated MCF10A cells, suggesting that the resistance acquired by some MCF10A cells after CSC treatment is due to increased expression of Bcl-xL and decreased expression of Bax. A decreased Bcl-xL to Bax ratio is also reported to cause nonsteroidal anti-inflammatory drug (NSAID)-induced cell death in colon cancer cells (Zhang et al., 2001) . Thus, the Bcl-xL to Bax ratio can be a critical factor for determining the death or survival of a cell in response to DNA damage. Although the mechanisms by which Bcl-xL mRNA levels are increased in MCF10A cells treated with CSC are not yet clear, it is possible that CSC treatment may induce the nuclear factor-kB (NF-kB) pathway, resulting an increased Bcl-xL gene expression as has been suggested earlier for human histiocytic lymphoma U-937 cells (Anto et al., 2002) . Furthermore, the Bcl-xL gene expression in response to CSC treatment can also be regulated through Ets, signal transducer and activator of transcription (STAT) and AP1 families of transcription factors, since the functional binding sites for these transcription factors are also present on Bcl-xL promoter (Sevilla et al., 2001) .
We then performed anchorage-independent growth assays in soft-agar to determine whether CSC treatment can induce transformation of MCF10A cells in vitro. We found that the CSC-treated MCF10A cells were capable of forming large size colonies as compared to the untreated cells, which did not grow in soft-agar. We further extended our studies to determine whether the transformation characteristics acquired by MCF10A cells after CSC treatment were stable. Cells from the soft-agar colonies were re-established in culture, and their transformation efficiency was determined by an anchorage-independent growth assay after 17 passages without CSC treatment. The re-established cell lines showed similar colony-formation efficiency in the softagar as seen with the parental MCF10A cells treated with CSC.
To further confirm that the MCF10A cells acquire a transformed phenotype after CSC treatment, we determined the expression level of NRP-1. The NRP-1 is a transmembrane receptor glycoprotein whose expression is known to be increased during the progression of breast, prostate, and lung tumors (Soker et al., 1998; Stephenson et al., 2002; Lantuejoul et al., 2003; Vanveldhuizen et al., 2003) . The NRP-1 serves as a vascular endothelial growth factor (VEGF) coreceptor and enhances VEGF receptor 2 (VEGFR2)/kinase insert domain-containing receptor (KDR) binding, tumor angiogenesis, and progression (Soker et al., 1998; Miao et al., 2000) . It has been suggested that the VEGF functions as an autocrine survival factor for neuropilin-expressing breast carcinoma cells (Bachelder et al., 2001) . Based on these findings, we tested the expression level of NRP-1 in CSC-induced transformation of noncancerous MCF10A cells into a cancerous phenotype. Our results suggest that the expression of NRP-1 was not only transiently increased in the CSCtreated MCF10A cells, its expression was also higher in the re-established transformed cell lines even after 17 passages. Our present in vitro studies suggest that cigarette smoke condensate is capable of transforming normal breast epithelial cells.
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Materials and methods
Maintenance of cells and treatment
The spontaneously immortalized human normal breast epithelial cell line MCF10A was grown at 371C under a humidified atmosphere of 5% CO 2 in DMEM/F-12 medium supplemented with 5% horse serum (Sigma Chemical Co., St Louis, MO, USA), 100 U/ml of penicillin, 100 mg/ml of streptomycin, 0.5 mg/ml hydrocortisone, 100 ng/ml cholera toxin, 10 mg/ml insulin, 10 ng/ml epidermal growth factor, and 1% (w/v) of Lglutamine. After cells reached 60% confluence, they were treated with CSC as shown in the figure legends.
Preparation of CSC
The CSC was prepared from the University of Kentucky Reference Cigarette 1R4F (9 mg tar and 0.8 mg. nicotine/ cigarette) adapting the previously described procedure (Hsu et al., 1991) . Briefly, the 'tar' or particulate phase of smoke was collected on a Cambridge filter pad from cigarettes smoked under standard Federal Trade Commission conditions (35 ml puff volume of a 2 s duration) (Pillsbury and Bright, 1972) and dissolved in dimethylsulfoxide (DMSO) at 40 mg/ml, aliquoted into small vials, and stored frozen at À801C. On the day of the experiment, each vial of CSC solution was opened and diluted in the cell culture medium to obtain the desired concentration, vortexed vigorously, and used for the treatment of cells. Control cells were treated with medium containing an equivalent amount of DMSO.
MTT assay
The anchorage-dependent growth of MCF10A cells after treatment with different concentrations of CSC for 72 h was measured using a MTT (3-(4,5-Dimethylthiazol-2yl-)-2,5-diphenyl tetrazolium bromide) cell proliferation assay kit from ATCC (Manassas, VA USA). In principle, the viable cell number is directly proportional to the purple formazan color of the reduced MTT dye, which can be quantitatively measured by spectrophotometry. Briefly, 500 cells were plated in quadruplicate in 96-well flat-bottom tissue culture plates and treated with CSC. After the 72 h of treatment, 10 ml of MTT reagent was added to each well and incubated at 371C for 4 h to allow the formation of purple color crystals of formazan. In total, 100 ml of detergent solution was added to each well, and the reaction mixture was incubated in dark for 2-4 h (or sometimes overnight) at room temperature. The developed color density was then measured spectrophotometrically at 570 nm using the micro plate reader (Vmax Kinetic Microplate Reader from Molecular Device, Sunnyvale, CA, USA).
FACScan analysis
A detergent and proteolytic enzyme-based technique was used for the nuclear isolation and analysis of DNA content of cells in different phases of the cell cycle. After treatment with CSC, the cells were harvested, processed and nuclei stained with propidium iodide, as described previously (Jaiswal et al., 2002) . The cellular DNA content was analysed using a BectonDickinson FACScan flow-cytometer. At least 10 000 cells per sample were considered in the gated regions used for calculations. The ranges for G 0 /G 1, S, G 2 /M and sub-G 1 phase cells were established based upon the corresponding DNA contents as displayed in the histograms. Results were analysed using the Modfit program and were expressed as the percentage of the total gated cells.
RNase protection assay
A transcriptional analysis of cell cycle-and apoptosis-related genes was performed using the RPA. Total RNA was isolated from the control and CSC-treated MCF10A cells as described previously (Narayan and Jaiswal, 1997) . The procedure for the RPA was essentially the same as described earlier (Das et al., 1995) . The custom human multiprobe template set containing Bcl-xL, p53, gadd45, c-fos, p21, bax, PCNA, L32, and GAPDH was obtained from BD Pharmingen (San Jose, CA, USA). L32 and GAPDH were controls. The multiprobe set was labeled with T7 RNA polymerase in the presence of [a-32 P]UTP and was used for RPA as per Pharmingen's protocol.
Western blot analysis
Changes in protein levels subsequent to the treatment of MCF10A cells with CSC were determined by Western blot analysis using whole-cell extracts, as described previously (Narayan and Jaiswal, 1997) . The antibodies used to detect the levels of the various proteins on the blots included mouse monoclonal antibodies specific for p53 (Oncogene Research Products, Cambridge, MA, USA); a-tubulin (Sigma Chem. Co., St Louis, MO, USA); Bax, Bcl-2, Bcl-xL, gadd45, PCNA, and p21 (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA).
Growth of cells in soft-agar
The anchorage-independent growth of MCF10A cells was determined by colony-formation efficiency in soft-agar. Approximately 5000 control and CSC-treated MCF10A cells were mixed at 371C with 2 ml of 0.33% (w/v) of soft-agar (Sigma Chem. Co., St Louis, MO, USA) and then poured onto a layer of previously set 1.5 ml of 0.9% soft-agar (w/v) in sixwell tissue culture plates. The soft-agar suspensions were prepared in the complete DMEM/F-12 medium for MCF10A cells, as described above for the maintenance of cells. Cells were incubated for 4 weeks then the growth of colonies was observed under an inverted microscope (Zeiss Axioplan-2 Imaging; Thornwood, NY, USA) at 20 Â magnification.
Establishment of cell lines derived from colonies from CSCtreated MCF10A cells
Randomly selected colonies were incubated in the complete DMEM/F-12 medium in 96-well plates. After 2 weeks, these cells were transferred into 12-well and then into six-well tissue culture plates. After 17 passages, the re-established cell lines were stored for further studies. In the present study, we used four clones derived from the 1 mg/ml of CSC-treated (CSC-MCF10A1 and CSC-MCF10A2) or 10 mg/ml of CSC-treated (CSC-MCF10A3 and CSC-MCF10A4) parental MCF10A cell line.
Immunohistochemistry
For the immunohistochemical staining, the parental MCF10A and MCF10A-derived cell lines (CSC-MCF10A1, CSC-MCF10A2, CSC-MCF10A3 and CSC-MCF10A4) were grown on coverslips. Only the parental cell line was treated with different concentrations of CSC for 72 h. On completion of the treatment, the cells were washed with phosphate-buffered saline (PBS) and fixed with 4% (w/v) paraformaldehyde in PBS for 30 min at 221C. Cells were washed three times with PBS and quenched for 30 min with PBS containing 50 mM ammonium chloride and 0.2% (v/v) Triton X-100. After washing with PBS three times, the cells were incubated for 2 h with the rabbit anti-NRP-1 antibody (1 : 200 dilution in PBS containing 5% goat serum and 0.2% Triton X-100; Zymed Laboratories, Inc., South San Francisco, CA, USA). Unbound antibodies were removed by washing in PBS. Secondary antirabbit IgG conjugated to crystalline tetramethylrhodamine isothiocyanate (TRITC) (1 : 750 dilution in PBS containing 5% goat serum and 0.2% Triton X-100; Sigma Chemical Co., St Louis, MO, USA) was added and incubated for 1 h. The heterochromatin of the cells was counter stained with 4 0 -6-diamidino-2-phenylindole (DAPI; Vector Laboratories, Inc., Burlington, CA, USA). The unbound secondary antibody was removed by washing with PBS, and the nuclei were stained by the inclusion of 4,6-diamidino-2-phenylindole (DAPI) in the mounting solution. Images were captured using a microscope (Zeiss upright microscope, Model Axioplan 2) fitted for photomicrography, with blue (450 nm) and red (640 nm) filter barriers being used to visualize DAPI and rhodamine staining, respectively.
